Repositório RCAAP

Mapeamento de epitopos funcionais do receptor CD14 por Phage Display e o reconhecimento de componentes bacterianos

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Ano

2022-12-06T17:28:21Z

Creators

Alves, Patrícia Terra

Análise bioquímica e funcional de uma metaloprotease PI (BpMPII) isolada da peçonha de Bothrops pauloensis

Fundação de Amparo a Pesquisa do Estado de Minas Gerais

Ano

2022-12-06T17:27:32Z

Creators

Achê, David Collares

Avaliação de biomarcadores salivares de estresse oxidativo após meia maratona em corredores amadores

Fundação de Amparo a Pesquisa do Estado de Minas Gerais

Ano

2022-12-06T17:29:10Z

Creators

Santos, Erickson Messias Bezerra dos

Caracterização da estabilização de eritrócitos por etanol

ABSTRACT - I The stability of a biological membrane depends on its biochemical composition. The membranes are formed by a lipid bilayer where proteins are integrally or peripherically embedded. The intrinsic stabilities of the lipid bilayer and membrane proteins will determine the overall stability of the membrane. In this literature review, we discuss some factors that can affect the membrane stability, as the nature of the fatty acids present in the membrane lipids and the effect of chaotropic and stabilizing solutes. An emphasis is given to the action of ethanol on the biological membranes. ABSTRACT - II Amostras de sangue provenientes de 12 voluntários do gênero masculino (20-28 anos) foram incubadas com 0 a 34 g.dl-1 de etanol e estudadas por espectrofotometria e microscopia de luz. Em 1.56 g.dl-1 de etanol os eritrócitos foram visualizados em um estado intacto ou expandido (R), e em 25 g.dl-1 de etanol, os eritrócitos apareceram em um estado contraído ou apertado (T), embora algumas estruturas sofreram ruptura nesta concentração de etanol. A dependência da percentagem de hemólise com a concentração de etanol mostrou três transições de natureza sigmoidal em toda extensão da concentração de etanol: uma desnaturação (D50R), uma estabilização (S50) e outra transição de desnaturação (D50T), com seus respectivos pontos médios em 11,17±0,078 (D50R), 20,73±0,056 (S50) e 27,20±0,097 g.dl-1 (D50T) de etanol em 0.9% de NaCl. A incubação com 0.6% de NaCl alterou os valores de D50R, S50 e o D50T para 10,35±0,25 (P<0,001), 21,48±0,034 (P<0,001) e 31,27±1,490 (P<0,05) g.dl-1, respectivamente. A diminuição do D50R produzida pelo decréscimo da concentração de NaCl indica que esta transição de desnaturação é devida somente à ação caotrópica do etanol. O aumento produzido em S50 e D50T indica que a estabilização e transição da desnaturação do estado T têm origem no aumento da pressão osmótica. A origem termodinâmica do efeito estabilizante do etanol sobre os eritrócitos foi explicada com base na teoria da hidratação preferencial.

Ano

2022-12-06T17:28:37Z

Creators

Silva, Luiz Fernando Gouvêa e

Avaliação da atividade mutagênica e carcinogênica da anfotericina B em células somáticas de Drosophila melanogaster

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Ano

2022-12-06T17:26:41Z

Creators

Saturnino, Rosiane Soares

Desenvolvimento de genossensor para diagnóstico de neuroblastoma

A novel electrochemical genosensor with modified graphite with poly(4-aminophenol) has been constructed for detection of neuroblastoma, a malignant tumor originating from embryonic precursor cells of the sympathetic nervous system and associated with the amplification MYCN oncogene. The produced genosensor exhibited distinct electric and morphological properties using rhodamine b, specie able to bind with DNA duplex, as indicator of the hybridization process. The detection limit was evaluated to be 0.47 umol.L-1 (N=3) and showed very high selectivity for the complementary DNA using serum sample. This DNA sensing platform was successfully applied to detect the MYCN, an important biomarker for neuroblastoma

Desenvolvimento de um imunossensor para detecção de proteína c reativa

This paper describes the development of immunosensor for C reactive protein (CRP), based in direct and indirect electrochemical detections. The anti-CRP probe was grafted to the platform sensitized with poly(3- aminothiophenol), and the interaction of CRP target with the immunosensor was carried directly or indirectly, using 4-aminoantipyrine (4-APP) as indicator. The immunosensor presents a linear response in the range from 75 ng·mL−1 to 150 μg·mL−1 and detection limit of 75ng·mL−1 (N=3). The biosensor specificity determined in the presence of non-specific target is also presented in this paper. Assays realized in real samples indicate that the immunosensor discriminates the serum samples from healthyand sick patients with efficiency.In addition, through atomic force microscopy, it was possible to observe differences between the immunosensor surface in the absence or presence of the CRP target

Desenvolvimento de peptideo bioativo modulador da resposta immune

Autoimmune diseases are a group of different diseases which are characterized by an immune disorder leading to decreased tolerance to components of the body itself. These diseases have many factors that trigger such as a decrease of the share or percentage of regulatory T cells (Tregs). The Transforming Growth Factor-beta 1 (TGF-β1) is involved in the suppression of the inflammatory response during the pathogenesis of autoimmune diseases (juvenile idiopathic arthritis, multiple sclerosis, diabetes), through the activation of this cell type. This cytokine is also associated with modulation of an inflammatory response either by increasing Treg cells and by modulating proinflammatory cytokines such as tumor necrosis factor alpha (TNF-α). The components found in both innate immune responses as adaptive must be considered potential targets for developing new drugs immune modulators. Thus, manipulation of Tregs is an attractive strategy for immunotherapy and hence, the use of mimetic peptide to TGF-β1 can be adopted to reduce the effects of severe autologous response, then creating an additional therapy for autoimmunity as well as for the treatment of inflammatory diseases. Our results show that we can select TGF-β1 mimetic peptides since we can prove by bioinformatics both bind to this receptor molecule. Thus, the peptides can be used as immunomodulators to combat inflammation and in the treatment of autoimmune diseases since they can modulate the production of TNF-α and IL-10.